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645are modest. These data are compatible with prior prospective
analyses (1–4).
An explanation for the high risk of CAD is not evident in our data
or those of others (2–4). In our cohort, SA people did not have
a higher prevalence of conventional CAD risk factors at baseline.
Furthermore, after adjustment for age, covariate control had little
effect on our CAD risk estimates. Proposed plausible mechanisms
include the increased prevalence of the metabolic syndrome,
increased genetic susceptibility to conventional risk factors, non-
conventional dyslipidemia traits, and lifestyle traits.
Our study is limited by the use of a 1978 to 1985 northern
California cohort devoid of more recent SA immigrants that might
have different traits related to risk of CAD. Other limitations
include absence of follow-up covariate measurements and data on
lipid subfractions, waist/hip circumference, dietary habits, and exer-
cise. Strengths include the large study population, long follow-up,
large number of ethnic groups for comparison, and control for many
CAD risk traits.
These data highlight the importance of deﬁning Asian
subgroups during health data collection (5) and improving risk
assessment tools in the SA population. Despite the absence of
proven mechanisms for high risk of CAD in SA people, it is
appropriate to pursue aggressive management of traditional risk
factors and to alert healthcare providers and SA patients.*Ashim Hajra, MDy
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the Coexistence of the
American Heart Association
and the American College
of Cardiology
As a nativeGerman,my heart was warmed by the insightful report by
Lüderitz et al. (1). I enjoyed reading about the common roots of the
German Cardiac Society and the American College of Cardiology
(ACC). The report provides an interesting perspective. Mentioned
in passing are the turbulent political times, culminating in World
War II and the Holocaust. Little is mentioned, however, about the
personal hardships endured by the thousands of refugee scientists.
Stripped of their possessions in Germany, many of these academics,
physicians, and other professionals lived in poverty in America,
deeply grateful and deeply unhappy. They were strangers and afraid
in a world they had not made, to paraphrase the poet A.E.
Houseman. According to Jean-Michel Palmier (2), doctors, biolo-
gists, and professors ofmedicine expelled fromGermany often found
themselves in the United States under awkward circumstances. For
physicians, it was difﬁcult to practice and avoid competition with the
American medical establishment. For academics, it was difﬁcult to
ﬁnd university appointments. Despite their specialized skills (and
their willingness to work) many remained unemployed in their
professions, with the notable exception of those who arrived already
with worldwide reputations. Especially the latter, were subsequently
referred to as “Hitler’s gift” to the rest of the world (3). Such
circumstances are also reﬂected in the origins of the ACC.
Although Paul Dudley White, a founding father of the Amer-ican Heart Association, is widely known as an internationalist (4),
the situation at hand was very complicated. Therefore, a group of
refugee scientists and practitioners of cardiovascular medicine came
together to create a new professional home for all cardiologists. Not
surprisingly, soon after World War II, and probably in response to
the creation of the ACC, the AHA changed its charter to that of
a health volunteer organization to become more inclusive and to
make room for the ACC (4). Both of our professional organizations
have peacefully coexisted ever since, to the beneﬁt of our entire
professiondespecially those who now add “FACC, FAHA” to
their credentials. Let’s relish our history!
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Dudley White. Boston, MA: Harvard University Press, 1986.ReplyI would like to thank Dr. Taegtmeyer very much indeed for his
ﬁne letter concerning our recent publication in the Journal (1).
I appreciate very much his comments and his personal experiences
in the twilight of the darkest period of Germany’s history. I am
chairman of the Task Force on History of Cardiology in
Germany; we are preparing a comprehensive report on the
political involvement of German and Austrian cardiologists
during the so-called Third Reich. I would be glad to inform
Dr. Taegtmeyer about our ongoing efforts nearer the time of
publication.
Once again, I thank Dr. Taegtmeyer for his interest in our work.
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Effect and the Accuracy of
Fractional Flow Reserve
We read with great interest the paper by Wittfeldt et al. (1), which
demonstrated that the novel adenosine diphosphate receptor
P2Y12 antagonist, ticagrelor, augments the adenosine-inducedincrease in coronary blood ﬂow velocity in healthy volunteers.
Ticagrelor has been shown to improve clinical outcomes in patients
with acute coronary syndromes compared with clopidogrel (2), and
its use is now recommended as ﬁrst-line therapy by international
guidelines (3,4).
The ﬁndings of this study may have important clinical impli-
cations in those patients who are taking ticagrelor and subsequently
require measurement of fractional ﬂow reserve (FFR) to assess the
hemodynamic signiﬁcance of coronary lesions. Accurate FFR
measurement requires maximal coronary hyperemia, and it is
recommended that this should be achieved with a continuous
intravenous infusion of adenosine at a rate of 140 mg/kg/min (5).
Although most studies have been performed using a maximum
infusion rate of 140 mg/kg/min, this may not achieve maximal
hyperemia in some patients. It has been suggested that higher doses
may be required to obtain accurate results (6).
Because ticagrelor has been shown to enhance adenosine-
induced vasodilatation, the degree of hyperemia obtained with
adenosine infusion may be greater than that obtained in patients
taking clopidogrel. This would lead to a lower FFR and a more
accurate reﬂection of the true functional signiﬁcance of a coronary
lesion.
The increasing use of ticagrelor in the future may also allow for the
routine use of intracoronary adenosine, because it has previously
been shown to be less reliable and more problematic than intrave-
nous infusion (6). If this is the case, the adoption of this more
simpliﬁed method may translate into an increased utilization of FFR
as a valuable investigative procedure with subsequent improved
patient outcomes and cost-effectiveness.*Sonny Palmer, BA, BSc, MBBS
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